The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neu...
Intra-articular injections are sometimes used to relieve pain for people with osteoarthritis. These include injections with corticosteroids, hyaluronan and stem cells. Corticosteroid injections are undertaken to deliver this high dose anti-inflammatory agent within the joint to reduce inflammation of the...
In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve pre...
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Janus Kinase Inhibitors/therapeutic use,
COVID-19/drug therapy,
Antiviral Agents/therapeutic use,
Ivermectin/therapeutic use,
Hydroxychloroquine/therapeutic use,
Plasma/immunology,
Fluvoxamine/therapeutic use,
Colchicine/therapeutic use,
Immunization, Passive,
Receptors, Interleukin-6/therapeutic use,
Lopinavir/therapeutic use,
Adrenal Cortex Hormones/therapeutic use
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/drug therapy,
Adrenal Cortex Hormones/therapeutic use,
Antiviral Agents/therapeutic use,
COVID-19/complications,
Pulmonary Embolism/complications,
Lung/pathology,
Anticoagulants/therapeutic use,
Dabigatran/therapeutic use,
Heparin/therapeutic use,
4-Hydroxycoumarins/therapeutic use,
Aspirin/therapeutic use
This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
In this ...
Falavigna, Maicon;
Stein, Cinara;
Amaral, José Luiz Gomes do;
Azevedo, Luciano Cesar Pontes de;
Belli, Karlyse Claudino;
Colpani, Verônica;
Cunha, Clóvis Arns da;
Dal-Pizzol, Felipe;
Dias, Maria Beatriz Souza;
Ferreira, Juliana Carvalho;
Freitas, Ana Paula da Rocha;
Gräf, Débora Dalmas;
Guimarães, Hélio Penna;
Lobo, Suzana Margareth Ajeje;
Monteiro, José Tadeu;
Nunes, Michelle Silva;
Oliveira, Maura Salaroli de;
Prado, Clementina Corah Lucas;
Santos, Vania Cristina Canuto;
Silva, Rosemeri Maurici da;
Sobreira, Marcone Lima;
Veiga, Viviane Cordeiro;
Vidal, Ávila Teixeira;
Xavier, Ricardo Machado;
Zavascki, Alexandre Prehn;
Machado, Flávia Ribeiro;
Carvalho, Carlos Roberto Ribeiro de.
Há diversas terapias sendo utilizadas ou propostas para a COVID-19, muitas carecendo de apropriada avaliação de efetividade e segurança. O propósito deste documento é elaborar recomendações para subsidiar decisões sobre o tratamento farmacológico de pacientes hospitalizados com COVID-19 no Bras...
COVID-19/drug therapy,
Adrenal Cortex Hormones/therapeutic use,
Hydroxychloroquine,
Anti-Bacterial Agents/therapeutic use,
Lopinavir/therapeutic use,
Immunization, Passive,
Oxygen Inhalation Therapy,
Thromboembolism/prevention & control,
Health Planning Guidelines,
SARS-CoV-2/drug effects
La presente guía de práctica clínica es un esfuerzo realizado por profesionales del Sistema
Integrado de Salud (SNIS) coordinado por el
Instituto Nacional de Salud (INS) ante la amenaza de la COVID-19 considerada una infección potencialmente mortal causada por el virus SARS-Cov2 y que actualmente rep...
El tratamiento oportuno de personas con COVID-19 busca minimizar el número de
complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú
(EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de
establecer recomendaciones ba...
